Butorphanol Tartrate Spray
NDC Package 72162-2099-2
Package Information
Butorphanol Tartrate sprays is butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Limitations of Use :Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration [see WARNINGS] reserve butorphanol tartrate nasal spray for use in patients for whom alternative treatment options (e.g., non-opioid analgesics):Have not been tolerated, or are not expected to be tolerated,Have not provided adequate analgesia, or are not expected to provide adequate analgesia Butorphanol tartrate nasal spray should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate. This formulation utilizes a spray delivery system. Marketed by Bryant Ranch Prepack, this product is identified by NDC 72162-2099 and is authorized under FDA application ANDA075499.
Identification & Billing
- RxCUI: 886634 - butorphanol tartrate 10 MG/mL Metered Dose Nasal Spray
- RxCUI: 886634 - butorphanol tartrate 1 MG/ACTUAT Metered Dose Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72162 - Bryant Ranch Prepack
- 72162-2099 - Butorphanol Tartrate
- 72162-2099-2 - 1 BOTTLE, SPRAY in 1 CONTAINER / 2.5 mL in 1 BOTTLE, SPRAY
- 72162-2099 - Butorphanol Tartrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72162-2099-2 identifies a specific commercial package of 1 bottle, spray in 1 container / 2.5 ml in 1 bottle, spray of Butorphanol Tartrate, a human prescription drug labeled by Bryant Ranch Prepack. This product is billed per "ML" milliliter and contains an estimated amount of 2.5 billable units per package. This spray is formulated for nasal use and contains butorphanol tartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bryant Ranch Prepack on December 04, 2002. The current certification is valid through December 31, 2027.
How is this Bryant Ranch Prepack product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72162209902. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 2.5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.